-
公开(公告)号:US07728042B2
公开(公告)日:2010-06-01
申请号:US10575145
申请日:2004-10-06
申请人: Istvan Eros , Ildiko Pannonhalmine Csoka , Erzsebet Soosne Csanyi , Attila Bodis , Erzsebet Lapis , Erzsebet Francsicsne Czinege , Emoke Kissne Csikos , Janos Illes
发明人: Istvan Eros , Ildiko Pannonhalmine Csoka , Erzsebet Soosne Csanyi , Attila Bodis , Erzsebet Lapis , Erzsebet Francsicsne Czinege , Emoke Kissne Csikos , Janos Illes
IPC分类号: A61K31/12
CPC分类号: A61K31/565 , A61K9/0014 , A61K9/06 , A61K9/1274 , A61K31/57 , A61K47/10 , A61K47/14 , A61K47/36
摘要: The invention relates to a liquid crystal gel containing polyoxyethylene-glyceryl-trioleate, propylene-glycol, isopropyl myristate and a hyaluronic acid salt or complex for use in the manufacture of transdermal pharmaceutical compositions and healing cosmetics. The invention also relates to transdermal pharmaceutical composition consists of an estrogen and a progestin component as well as a liquid crystal gel containing polyoxyethylene-glyceryl-trioleate, propylene-glycol, isopropyl myristate and a hyaluronic acid salt or complex. The invention can be applied for transdermal hormone replacement therapy and for other transdermal depending on the active principles included.
摘要翻译: 本发明涉及含有聚氧乙烯 - 甘油三油酸酯,丙二醇,肉豆蔻酸异丙酯和用于制造透皮药物组合物和愈合化妆品的透明质酸盐或络合物的液晶凝胶。 本发明还涉及由雌激素和孕激素组分组成的透皮药物组合物,以及含有聚氧乙烯 - 甘油三油酸酯,丙二醇,肉豆蔻酸异丙酯和透明质酸盐或络合物的液晶凝胶。 本发明可以应用于透皮激素替代疗法和其它透皮贴剂,这取决于包括的活性成分。